RxDoctor Payments Data

McKenzie Kusgen, NP

Family · Sedalia, MONPI 1619593597

Payments from drug & device makers

$1,938in general payments, 2019–2025

Across 141 payments — averaging $13.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$917
  • Johnson & Johnson$354
  • Amgen$119
  • Sanofi-aventis U.S. LLC$111
  • Amarin Pharma, Inc.$96
  • Merck$76
  • plus $265 from 9 others

What the payments were for

  • Food & beverage$1,938100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,938 in reported general payments places this provider in the 80th percentile of 3,812 family providers in Missouri.

See all family providers in Missouri

Medicare billing

Part B allowed, 2024
$110,563
Medicare patients
784
Services billed
1,144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban355$309,631
EliquisApixaban336$293,448
EntrestoSacubitril/Valsartan236$208,181
JardianceEmpagliflozin105$84,199
Repatha SureclickEvolocumab20$14,881
VascepaIcosapent Ethyl22$10,804
Metoprolol Succinate574$6,077
Atorvastatin Calcium518$3,010
Ezetimibe236$2,850
Potassium Chloride239$2,817
Torsemide175$2,471
Diltiazem 24hr Er (Cd)Diltiazem Hcl98$2,363
Carvedilol411$2,106
Amiodarone Hcl210$1,726
Lisinopril286$1,690

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$354$309,631355 claims
PfizerEliquis$46$293,448336 claims
NovartisEntresto$917$208,181236 claims
Boehringer IngelheimJardiance$15$84,199105 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,812 family providers in Missouri.

Other family in Sedalia

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →